| DANIEL M. SCHMITT |
ACTU |
Common Stock |
Tax liability |
-44.8% |
|
|
-121,874 |
150,181 |
13 Feb 2026 |
Direct |
| DANIEL M. SCHMITT |
ACTU |
Common Stock |
Options Exercise |
|
|
|
272,055 |
272,055 |
13 Feb 2026 |
Direct |
| DANIEL M. SCHMITT |
ACTU |
Restricted Stock Units |
Options Exercise |
-50% |
|
|
-272,055 |
272,056 |
13 Feb 2026 |
Direct |
| TODD S. THOMSON |
ACTU |
Common Stock |
Sale |
-23.6% |
$1,624,000 |
$5.80 |
-280,000 |
904,795 |
05 Jan 2026 |
By Kairos Venture Partners II, L.P. |
| Bios Equity COF, LP |
ACTU |
Common Stock |
Purchase |
57.1% |
$499,996 |
$7.00 |
71,428 |
196,428 |
27 Jun 2025 |
Directly held by Bios 2024 Co-Invest, LP |
| Bios Equity COF, LP |
ACTU |
Warrant (Right to Buy) |
Purchase |
|
|
|
71,428 |
71,428 |
27 Jun 2025 |
Directly held by Bios 2024 Co-Invest, LP |
| Leslie W. Kreis |
ACTU |
Common Stock |
Purchase |
57.1% |
$499,996 |
$7.00 |
71,428 |
196,428 |
27 Jun 2025 |
Directly held by Bios 2024 Co-Invest, LP |
| Leslie W. Kreis |
ACTU |
Warrant (Right to Buy) |
Purchase |
|
|
|
71,428 |
71,428 |
27 Jun 2025 |
Directly held by Bios 2024 Co-Invest, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Purchase |
57.1% |
$499,996 |
$7.00 |
71,428 |
196,428 |
27 Jun 2025 |
Directly held by Bios 2024 Co-Invest, LP |
| Aaron G.L. Fletcher |
ACTU |
Warrant (Right to Buy) |
Purchase |
|
|
|
71,428 |
71,428 |
27 Jun 2025 |
Directly held by Bios 2024 Co-Invest, LP |
| TODD S. THOMSON |
ACTU |
Stock Options |
Award |
|
|
|
15,000 |
15,000 |
22 May 2025 |
Direct |
| Roger Sawhney |
ACTU |
Stock Options |
Award |
|
|
|
15,000 |
15,000 |
22 May 2025 |
Direct |
| Dan Zabrowski |
ACTU |
Stock Options |
Award |
|
|
|
15,000 |
15,000 |
22 May 2025 |
Direct |
| Aaron G.L. Fletcher |
ACTU |
Stock Options |
Award |
|
|
|
15,000 |
15,000 |
22 May 2025 |
Direct |
| Jason A. Keyes |
ACTU |
Stock Options |
Award |
|
|
|
15,000 |
15,000 |
22 May 2025 |
Direct |
| AMY L. RONNEBERG |
ACTU |
Stock Options |
Award |
|
|
|
15,000 |
15,000 |
22 May 2025 |
Direct |
| DANIEL M. SCHMITT |
ACTU |
Employee Stock Option (right to buy) |
Award |
|
|
|
270,788 |
204,285 |
01 Apr 2025 |
Direct |
| Andrew Paul Mazar |
ACTU |
Employee Stock Option (right to buy) |
Award |
|
|
|
161,392 |
110,346 |
01 Apr 2025 |
Direct |
| PAUL J. LYTLE |
ACTU |
Employee Stock Option (right to buy) |
Award |
|
|
|
91,293 |
49,394 |
01 Apr 2025 |
Direct |
| Bios Equity COF, LP |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-2,324 |
131,248 |
14 Aug 2024 |
Directly held by Bios Fund II NT, LP |
| Bios Equity COF, LP |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-17,361 |
980,433 |
14 Aug 2024 |
Directly held by Bios Fund II QP, LP |
| Bios Equity COF, LP |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-5,314 |
300,143 |
14 Aug 2024 |
Directly held by Bios Fund II, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-2,324 |
131,248 |
14 Aug 2024 |
Directly held by Bios Fund II NT, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-17,361 |
980,433 |
14 Aug 2024 |
Directly held by Bios Fund II QP, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-5,314 |
300,143 |
14 Aug 2024 |
Directly held by Bios Fund II, LP |
| Leslie W. Kreis |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-2,324 |
131,248 |
14 Aug 2024 |
Directly held by Bios Fund II NT, LP |
| Leslie W. Kreis |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-17,361 |
980,433 |
14 Aug 2024 |
Directly held by Bios Fund II QP, LP |
| Leslie W. Kreis |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-5,314 |
300,143 |
14 Aug 2024 |
Directly held by Bios Fund II, LP |
| TODD S. THOMSON |
ACTU |
Common Stock |
Sale |
-1.56% |
|
|
-18,750 |
1,184,795 |
14 Aug 2024 |
By KVP II, L.P. |
| TODD S. THOMSON |
ACTU |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
2.42% |
|
|
28,464 |
1,203,545 |
14 Aug 2024 |
By KVP II, L.P. |
| TODD S. THOMSON |
ACTU |
Common Stock |
Conversion of derivative security |
|
|
|
254,735 |
254,735 |
14 Aug 2024 |
By Kairos-Actuate SPV, L.P. |
| TODD S. THOMSON |
ACTU |
Common Stock |
Conversion of derivative security |
|
|
|
321,781 |
321,781 |
14 Aug 2024 |
By Kairos SPV Fund, LLC |
| TODD S. THOMSON |
ACTU |
Common Stock |
Conversion of derivative security |
|
|
|
873,033 |
873,033 |
14 Aug 2024 |
By KVOI, L.P. |
| TODD S. THOMSON |
ACTU |
Common Stock |
Conversion of derivative security |
2383.4% |
|
|
1,127,763 |
1,175,081 |
14 Aug 2024 |
By KVP II, L.P. |
| TODD S. THOMSON |
ACTU |
Warrant (Right to Buy) |
Exercise of in-the-money or at-the-money derivative security |
|
|
|
28,464 |
0 |
14 Aug 2024 |
By KVP II, L.P. |
| TODD S. THOMSON |
ACTU |
Series C Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
49,984 |
0 |
14 Aug 2024 |
By Kairos SPV Fund, LLC |
| TODD S. THOMSON |
ACTU |
Series C Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
24,138 |
0 |
14 Aug 2024 |
By Kairos-Actuate SPV, L.P. |
| TODD S. THOMSON |
ACTU |
Series B-4 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
132,908 |
0 |
14 Aug 2024 |
By Kairos SPV Fund, LLC |
| TODD S. THOMSON |
ACTU |
Series B-4 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
230,597 |
0 |
14 Aug 2024 |
By Kairos-Actuate SPV, L.P. |
| TODD S. THOMSON |
ACTU |
Series B-3 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
138,889 |
0 |
14 Aug 2024 |
By Kairos SPV Fund, LLC |
| TODD S. THOMSON |
ACTU |
Series B-3 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
146,870 |
0 |
14 Aug 2024 |
By KVOI, L.P. |
| TODD S. THOMSON |
ACTU |
Series B-3 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
69,445 |
0 |
14 Aug 2024 |
By KVP II, L.P. |
| TODD S. THOMSON |
ACTU |
Series B-2 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
726,163 |
0 |
14 Aug 2024 |
By KVOI, L.P. |
| TODD S. THOMSON |
ACTU |
Series B-1 Redeemable Convertible Preferred Stock |
Conversion of derivative security |
|
|
|
1,058,318 |
0 |
14 Aug 2024 |
By KVP II, L.P. |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-2,324 |
131,248 |
14 Aug 2024 |
Directly held by Bios Fund II NT, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
2.71% |
|
|
3,528 |
133,572 |
14 Aug 2024 |
Directly held by Bios Fund II NT, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-17,361 |
980,433 |
14 Aug 2024 |
Directly held by Bios Fund II QP, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
2.71% |
|
|
26,355 |
997,794 |
14 Aug 2024 |
Directly held by Bios Fund II QP, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Sale |
-1.74% |
|
|
-5,314 |
300,143 |
14 Aug 2024 |
Directly held by Bios Fund II, LP |
| Aaron G.L. Fletcher |
ACTU |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
2.71% |
|
|
8,068 |
305,457 |
14 Aug 2024 |
Directly held by Bios Fund II, LP |